SCHEMBL7080447

SCHEMBL7080447

N#Cc1ccccc1CNc1ccc(C(=S)c2sccc2Cl)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 1/20 0.39
SCN5A Q14524 1/20 0.39
SCN8A Q9UQD0 1/20 0.39
MAPT P10636 5/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PLA2G1B P04054 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
P2RX7 Q99572 1/20 0.37
GAA P10253 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 1/20 0.34
MAP3K8 P41279 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7079269 0.88 SCN1A (0.41) SCN1ASCN5ASCN8AMAPTMEN1
SCHEMBL7080247 0.86 SCN1A (0.38) SCN1ASCN5ASCN8AMAPTMEN1
SCHEMBL7080443 0.82 MAPK14 (0.37) MAPTKMT2ACYP1A2GAAALDH1A1
SCHEMBL11593195 0.75 MAPT (0.61) SCN1ASCN5ASCN8AMAPTMEN1
SCHEMBL7076675 0.74 MAPK13 (0.47) MAPTMEN1KMT2AL3MBTL1CYP1A2
SCHEMBL7077185 0.73 MAPK13 (0.37) MAPTMEN1KMT2AGAAALDH1A1
SCHEMBL11567164 0.72 CYP2C9 (0.69) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL7074987 0.69 MAPK14 (0.56) KMT2AALDH1A1
SCHEMBL7082053 0.69 MAPK14 (0.55) MAPTMEN1KMT2ACYP1A2CYP2D6
SCHEMBL7079266 0.69 MAPK13 (0.47) MAPTCYP1A2GAAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 SCN1A 4259/4885SCN5A 4486/4885SCN8A 4652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.